AGA Family of Websites:

Improve your care for patients with EGIDs

Purchase the 2021 Freston on-demand course and learn the latest therapeutic advances for adults and children with eosinophilic GI disorders (EGIDs). 

Over the past two decades, eosinophilic GI disorders (EGIDs) have emerged as a leading cause of esophageal, stomach and intestinal disorders in children and adults around the world. Watch the 2021 James W. Freston Single Topic Conference on-demand course on Eosinophils in Gastrointestinal Disease: Pathways and Crossroads to get current on this evolving area of patient care. The course will cover:

  • The impact of EGIDs on esophagus, stomach and intestinal disorders including inflammatory bowel disease, irritable bowel syndrome and non-ulcer dyspepsia. 
  • Results of current research studies and novel therapeutics from recent Phase 3 clinical trials.
  • The underpinnings of EGIDs with a review of its genetics, epithelial barrier dysfunction, remodeling and mast cell interactions.
  • The latest therapeutic advances for adults and children with a range of esophageal disorders. 

2021 Freston On-Demand is accredited for 13.75 CME and 13.75 MOC and will equip you with the tools and research to mitigate EGID-related conditions.

Your hub for GI education is
AGA University

AGA clinical guidance

Find the latest evidence-based recommendations for treating your patients.